Is Genetic Engineering Cloning Part Of Our Future?

Genetic engineering cloning is only one small aspect of a science which is still in its infancy, but which has the potential to change everything about the way the world is, the way people live, the way food is grown, and the way illnesses are treated. It is, however, one of the most significant and potentially far reaching applications of the technology as it deals directly with the creation of a human being to order, from the existing genes of another. If genetic engineering as a whole is controversial, this potential application of it is likely to create more extreme reactions than any other.

Cloning an existing body is not a true application of genetic engineering in the sense that genes are not actually manipulated to create something new, but simply duplicated to create a copy of something which already exists. This can be achieved by duplicating the genes of a being which already exists, either alive or recently dead. These genes can then be implanted into a human egg, so that they can incubate and grow in the usual way. The result of this will be a body identical to the one from which the genetic material was taken.

Which brings us to the obvious question of why anyone would want to do this in the first place? The answer is largely to do with potential medical practices which may be possible in future years. As everyone knows, there are some medical patients who cannot be saved without the donation of an organ into the ailing body. This organ will usually come from a donor, someone who has recently died and expressed a wish for their body parts to be used after their death. There will be a significant chance that the organ will be accepted by the body if it is a good match, but there are no guarantees.

types of genetic engineering

As a kind of precursor to genetic engineering cloning there have been experiments using animal organs to take the place of human ones. These animal organs are highly likely to be rejected by the human body, no matter what the original source. It is for this reason that experiments are being carried out into the possibility of creating animals with a genetic blueprint similar to that of humans, so that the likelihood of a human body accepting the organ can be greatly increased. The ethics of such experiments are, of course, hotly debated.

Genuine cloning would, of course, provide a more stable alternative to any of these procedures. The organ grown in the cloned body will be a perfect match for the original organ as it will have the identical genetic profile. The only difficulty will be carrying out the actual transplant, as these will always involve risk. The possibilities exist for this type of genetic clone to be produced from every living human, so that replacement organs are available for everyone. Of course, this is all a long way off, but proponents of the technology are quick to point out the possibilities.

genetic engineering

It remains to be seen, of course, whether or not genetic engineering cloning plays any significant role in future medical developments. The availability of the technology is not in doubt, and neither is its potential effectiveness. What is in doubt is whether many of these applications are financially viable, and, of course, we still know so little about human DNA so the results would be unpredictable. There are also the ethical issues, which will doubtless be discussed at length in government meetings for many years to come. Only time will decide the future of genetic engineering cloning.

 

 

 

Genetic Engineering News:

 

Biotechnology timeline: Humans have manipulated genes since the 'dawn of civilization' - Genetic Literacy Project

Genetic Literacy Project

Biotechnology timeline: Humans have manipulated genes since the 'dawn of civilization'
Genetic Literacy Project
The origins of biotechnology culminate with the birth of genetic engineering. There were two key events that have come to be seen as scientific breakthroughs beginning the era that would unite genetics with biotechnology: One was the 1953 discovery of .

..


Human Neural Stem Cell Therapy for Chronic Ischemic Stroke | GEN - Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News

Human Neural Stem Cell Therapy for Chronic Ischemic Stroke | GEN
Genetic Engineering & Biotechnology News
Chronic disability after stroke represents a major unmet neurologic need. ReNeuron's development of a human neural stem cell (hNSC) therapy for chronic .

and more »
..

Genetically enhanced, cord-blood derived immune cells strike B-cell . - Science Daily

Genetically enhanced, cord-blood derived immune cells strike B-cell .
Science Daily
Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific .

and more »
..


Broad Institute Joins CRISPR Patent Pool Talks | GEN - Genetic Engineering & Biotechnology News (blog)

Broad Institute Joins CRISPR Patent Pool Talks | GEN
Genetic Engineering & Biotechnology News (blog)
The Broad Institute of MIT and Harvard said today they have joined discussions to create a nonexclusive CRISPR/Cas9 joint licensing pool being coordinated by .

and more »
..


FDA Panel Recommends Approval for Gene-Altering Leukemia Treatment - New York Times

New York Times

FDA Panel Recommends Approval for Gene-Altering Leukemia Treatment
New York Times
The treatment requires removing millions of a patient's T-cells EUR” a type of white blood cell often called soldiers of the immune system EUR” and genetically engineering them to kill cancer cells. The technique employs a disabled form of H.I.V., the .
BLA 125646 Tisagenlecleucel 1 FDA Briefing Document Oncologic Drugs Advisory Committee Meeting BLA 125646 .FDA
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ)EUR”Patient Version - National Cancer InstituteNational Cancer Institute
FDA Panel OKs What May Soon Be First Gene Therapy Approved in USHealthDay

all 245 news articles »
..


The race to revive woolly mammoths using ancient DNA - CBS News

CBS News

The race to revive woolly mammoths using ancient DNA
CBS News
And why they don't get cancer is in their genes. If we can figure that out, we can use this genetic engineering to solve cancer," he said. The author also addressed the ethical concerns related to these types of genetic engineering practices. "The idea .
Woolly Mammoths Coming Back To LifeChronicle Day
Peter Thiel Is Funding the Effort to Bring Woolly Mammoths Back to LifeMIT Technology Review

all 25 news articles »
..


Gene therapy to kill cancer moves a step closer to market - CNET - CNET

CNET

Gene therapy to kill cancer moves a step closer to market - CNET
CNET
An advisory panel says it's time patients had access to gene-altering treatments. If approved, the first to make it to market would take on a stubborn form of .

and more »
..


How robots could affect the workplace of the future - Tamworth Herald

Tamworth Herald

How robots could affect the workplace of the future
Tamworth Herald
Science fiction is quickly becoming fact as robots become more and more common in our lives; according to futurologists, cyborgs, self-driving vehicles, genetic engineering, and space exploration are all likely to have a huge impact on the world of .

and more »
..


 

share